Rangers Face Questions After Chermiti's ACL Injury

Youssef Chermiti’s ACL injury has ripped a hole straight through Rangers’ season – and for many supporters, it has also exposed old wounds the club never quite allowed to heal.

The striker’s long-term lay-off is a human story first. That came through clearly.

“Of course Chermiti's health should be the main priority and I hope he recovers,” wrote Graeme, before turning sharply to a wider frustration that has simmered for years. To him, this is “classic Rangers”: key assets not moved on at peak value, and the financial impact now biting hard. Alfredo Morelos, Ryan Kent, Nicolas Raskin – the names roll off the tongue like a charge sheet. The theme is the same: hesitation, then depreciation.

Others stripped it back to the basics of bad luck.

“Poor guy. It's a terrible injury but could happen at any time. No point complaining about it. Gutted for the lad,” said Ian, refusing to turn a medical misfortune into a blame game. The sympathy is real, but it doesn’t erase the sporting problem that now stares the club in the face.

A race for a replacement

Sally cut straight to the football reality. Chermiti is young, and an ACL can heal, but the brutal truth of the modern market hung over her message. Players returning from such injuries rarely command the same fee. “It's unlikely he will be the same player and his value will drop dramatically in the transfer market. Rangers now need to find another striker fast.”

That urgency is echoed elsewhere. Another Ian spelled out the immediate pressure on those still standing. “Ryan Naderi and Bojan Miovski have to step up,” he insisted, pointing to the timing as much as the scale of the blow. With European ties already a slog at full strength, losing Chermiti now feels, to many, like a twist the squad could least afford.

The pressure doesn’t just sit in the dressing room, though. It’s creeping upstairs.

Financial fears and boardroom bets

Iain’s concern wasn’t about tactics or formations. It was about the balance sheet. “I worry that we're spending ourselves into a black hole, £6m signings here, there and everywhere,” he warned. His questions were blunt and pointed: have the board gambled on Europa League qualification and spent the money before it arrived? Have they banked on Chermiti and/or Raskin being sold for big fees that now may never materialise? “Where is this money coming from?”

That anxiety taps into a wider unease. Supporters have watched the club take ambitious swings in the market before. Some have landed. Others have left scars. An injury of this magnitude to a major asset doesn’t just disrupt the team sheet; it shakes the financial model built around it.

The £22m that never was

James’ verdict came with a sting. “Should have left him out of the team, and definitely should have sold him for £22m,” he said, crystallising a line of thought many share but few phrase so starkly. For that section of the support, Chermiti’s injury isn’t only a cruel twist of fate. It’s the moment a missed opportunity becomes a costly mistake.

The debate now rages on two fronts. On the pitch, Rangers must somehow replace a focal point at the sharp end of the season, asking Naderi, Miovski and others to grow into roles that suddenly feel heavier. Off it, the board faces a support asking harder questions about risk, reward and the timing of big decisions.

Chermiti will begin the long, lonely road back from an ACL. Rangers, in their own way, are about to start a recovery of their own. The difference is clear: his rehab has a defined plan. Does the club’s?